Skip to main content

Advertisement

SpringerLink
Log in

Budd-Chiari syndrome

  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Opinion statement

  • Many options are available to diagnose and treat patients with the Budd-Chiari syndrome who present with either thrombotic or non-thrombotic occlusion of the major hepatic veins and or vena cava.

  • The goal of therapy is to alleviate venous obstruction and to preserve hepatic function.

  • Low-sodium diets, diuretics, and therapeutic paracentesis are generally ineffective, except for the rare patient who presents with volume overload and incomplete hepatic venous occlusion.

  • Anticoagulants and thrombolytics may be appropriate for selected patients with acute thrombotic venous obstruction.

  • Percutaneous transluminal angioplasty (PTA) of hepatic venous stenoses or caval webs with or without placement of intraluminal stents yield excellent short-term results, but additional studies are warranted to assess long-term efficacy.

  • Transjugular intrahepatic portosystemic shunts (TIPS) may be effective for patients with subacute or chronic disease and ascites refractory to sodium restriction and diuretics. Intrahepatic stents may also serve as a bridge to transplantation for selected patients presenting with fulminant hepatic failure consequent to hepatic venous occlusion. Additional studies will be necessary to assess the role of TIPS in the armamentarium of therapies for patients with the Budd-Chiari syndrome.

  • Decompressive shunts, reconstruction of the vena cava and hepatic venous ostia, transatrial membranotomy, and dorsocranial resection of the liver with hepatoatrial anastomosis are appropriate options for patients with acute or subacute disease who are not candidates for, or fail less invasive therapies. The majority of patients benefit with improvement in liver function tests, ascites, and liver histology; however, hepatic function may deteriorate in patients with marginal reserve.

  • Liver transplantation is reserved for patients with Budd-Chiari syndrome who present with fulminant hepatic failure or end-stage liver disease with portal hypertensive complications. Transplantation is also appropriate for patients who deteriorate after failed attempts at surgical shunting.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Budd G: On Diseases of the Liver. London: John Churchill; 1845:146. Of significant historical interest.

    Google Scholar 

  2. Chiari H: Ueber die selbstandige phlebitis obliterans der hauptstamme der venae hepaticae als todesursache. Beitr Z Pathol Anat 1899, 26:1–18. Of significant historical interest.

    Google Scholar 

  3. WangZG, Jones RS: Budd-Chiari syndrome. Curr Probl Surg 1996, 33:83–211. An exhaustive review of the etiology, clinical manifestations, and diagnostic evaluation of patients with Budd-Chiari syndrome. Surgical approaches to hepatic outflow obstruction are covered in detail.

    Article  PubMed  CAS  Google Scholar 

  4. Boughton BJ: Hepatic and portal vein-thrombosis. BMJ 1991, 302:192–193.

    PubMed  CAS  Google Scholar 

  5. Valla D, Casadevall N, Lacombe C, et al.: Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med 1985, 103:329–334.

    PubMed  CAS  Google Scholar 

  6. Ganguli SC, Ramzan NN, McKusick MA, et al.: Budd-Chiari syndrome in patients with hematological disease: a therapeutic challenge. Hepatology 1998, 27:1157–1161. An excellent review of diagnostic and treatment options for Budd-Chiari syndrome. This concise review discusses surgical and non-surgical approaches to venous outflow obstruction.

    Article  PubMed  CAS  Google Scholar 

  7. Levy VG, Ruskone A, Baillou C, et al.: Polycythemia and the Budd-Chiari syndrome: study of serum erythropoietin and bone marrow erythroid progenitors. Hepatology 1985, 5:858–861.

    Article  PubMed  CAS  Google Scholar 

  8. Hoffman R, Nimer A, Lanier N, et al.: Budd-Chiari syndrome associated with factor V Leiden mutation: a report of 6 patients. Liver Transpl and Surg 1999, 5:96–100.

    Article  CAS  Google Scholar 

  9. Gambaro G, Patrassi G, Pittarello F, et al.: Budd-Chiari syndrome, during nephrotic relapse in a patient with resistance to activated protein C clotting inhibitor. Am J Kidney Dis 1998, 32:657–660.

    PubMed  CAS  Google Scholar 

  10. Mohanty D, Shetty S, Narayanan TS, Abraham P: Factor V Leiden mutation and Budd-Chiari syndrome. Blood 1998, 92:1838–1839.

    PubMed  CAS  Google Scholar 

  11. Mahmoud AEA, Elias E, Beauchamp N, Wilde JT: Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut 1997, 40:798–800.

    Article  PubMed  CAS  Google Scholar 

  12. Delarive J, Gonvers J-J: Budd-Chiari syndrome related to factor V Leiden mutation. Am J Gastroenterol 1998, 93:651–652.

    Article  PubMed  CAS  Google Scholar 

  13. Tilanus HW: Budd-Chiari syndrome. Br J Surg 1995, 82:1023–1030. A concise review of the etiology, pathology, clinical manifestations, and treatment options for patients with Budd-Chiari syndrome.

    Article  PubMed  CAS  Google Scholar 

  14. Das M, Carroll SF: Antithrombin III deficiency: an etiology of Budd-Chiari syndrome. Surgery 1985, 97:242–246.

    PubMed  CAS  Google Scholar 

  15. Bourliere M, Le Treut YP, Arnoux D, et al.: Acute Budd-Chiari syndrome with hepatic failure and obstruction of the inferior vena cava as presenting manifestations of hereditary protein C deficiency. Gut 1990, 31:949–952.

    PubMed  CAS  Google Scholar 

  16. Valla D, Dhumeaux D, Babany G, et al.: Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd-Chiari syndrome. Gastroenterology 1987, 93:569–575.

    PubMed  CAS  Google Scholar 

  17. Sugano S, Suzuki T, Makino H, et al.: Budd-Chiari syndrome attributed to protein C deficiency. Am J Gastroenterol 1996, 91:777–779.

    PubMed  CAS  Google Scholar 

  18. Ludwig J, Hashimoto E, McGill DB, van HeerdenJA: Classification of hepatic venous outflow obstruction: ambiguous terminology of the Budd-Chiari syndrome. Mayo Clin Proc 1990, 65:51–55.

    PubMed  CAS  Google Scholar 

  19. Ludwig J: Abnormal blood vessels and hemorrhages. In Practical Liver Biopsy Interpretation: Diagnostic Algorithms. Vol. 1. Edited by Rogers P. Chicago: ASCP Press; 1992:233–258.

    Google Scholar 

  20. Scheuer PJ, Lefkowitch JH: Vascular disorders. In Liver Biopsy Interpretation. Vol. 31. London: W. B. Saunders Company Ltd.; 1994:182–193.

    Google Scholar 

  21. Tanaka M, Wanless IR: Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules. Hepatology 1998, 27:488–496.

    Article  PubMed  CAS  Google Scholar 

  22. Langnas AN, Sorrell MF: The Budd-Chiari syndrome: a therapeutic gordian knot? Semin Liver Dis 1993, 13:352–359.

    Article  PubMed  CAS  Google Scholar 

  23. Bismuth H, Sherlock DJ: Portasystemic shunting versus liver transplantation for the Budd-Chiari syndrome. Ann Surg 1991, 214:581–589.

    Article  PubMed  CAS  Google Scholar 

  24. Sivaram M, Chawla Y, Kumar B: Stasis dermatitis-a new cutaneous manifestation of Budd-Chiari syndrome. Int J Dermatol 1998, 37:397–398.

    Article  PubMed  CAS  Google Scholar 

  25. MahmoudAE, Mendoza A, Meshikhes AN, et al.: Clinical spectrum, investigations and treatment of Budd-Chiari syndrome. QJM 1996, 89:37–43. A thorough review of the clinical manifestations, etiology, and available treatment options for patients with hepatic venous outflow obstruction.

    PubMed  CAS  Google Scholar 

  26. Bolondi L, Gaiani S, Li Bassi S, et al.: Diagnosis of Budd-Chiari syndrome by pulsed doppler ultrasound. Gastroenterology 1991, 100:1324–1331.

    PubMed  CAS  Google Scholar 

  27. Kane R, Eustace S: Diagnosis of Budd-Chiari syndrome: comparison between sonography and MR angiography. Radiology 1995, 195:117–121.

    PubMed  CAS  Google Scholar 

  28. Pompili M, Rapaccini GL, Teofili L, et al.: Ultrasounddoppler diagnosis of Budd-Chiari syndrome. J Clin Gastroenterol 1990, 12:591–594.

    Article  PubMed  CAS  Google Scholar 

  29. Ralls PW, Johnson MB, Radin DR, et al.: Budd-Chiari syndrome: detection with color doppler sonography. Am J Roentgenol 1992, 159:113–116.

    CAS  Google Scholar 

  30. Lim JH, Park JH, Auh YH: Membranous obstruction of the inferior vena cava: comparison of findings at sonography, CT, and venography. Am J Roentgenol 1992, 159:515–520.

    CAS  Google Scholar 

  31. Millener P, Grant EG, Rose S, et al.: Color doppler imaging findings in patients with Budd-Chiari syndrome: correlation with venographic findings. Am J Roentgenol 1993, 161:307–312.

    CAS  Google Scholar 

  32. Mulholland JP, Fong SM, Kafaghi FA, Fong W: Budd-Chiari syndrome: diagnosis with ultrasound and nuclear medicine calcium colloid liver scan following non-diagnostic contrasted CT scan. Australas Radiol 1997, 41:53–56.

    PubMed  CAS  Google Scholar 

  33. Kao P-F, Tzen K-Y, You D-L, et al.: Radionuclide inferior venocavagraphy in Budd-Chiari syndrome before and after angioplasty. Clin Nucl Med 1997, 22:485–487.

    Article  PubMed  CAS  Google Scholar 

  34. Mergo PJ, Ros PR: Imaging of diffuse liver disease. Radiol Clin North Am 1998, 36:365–375.

    Article  PubMed  CAS  Google Scholar 

  35. Ueda K, Matsui O, Kadoya M, et al.: CTAP in Budd-Chiari syndrome: evaluation of intrahepatic portal flow. Abdom Imaging 1998, 23:304–308.

    Article  PubMed  CAS  Google Scholar 

  36. Noone TC, Semelka RC, Woosley JT, Pisano ED: Ultrasound and MR findings in acute Budd-Chiari syndrome with histopathologic correlation. J Comput Assist Tomogr 1996, 20:819–822.

    Article  PubMed  CAS  Google Scholar 

  37. Henderson JM, Warren D, Millikan WJ, et al.: Surgical options, hematologic evaluation, and pathologic changes in Budd-Chiari syndrome. Am J Surg 1990, 159:41–50.

    Article  PubMed  CAS  Google Scholar 

  38. Mitchell MC, Boitnott JK, Kaufman S, et al.: Budd-Chiari syndrome: etiology, diagnosis and management. Medicine 1982, 61:199–218.

    Article  PubMed  CAS  Google Scholar 

  39. McCarthy PM, van HeerdenJA, Adson MA, et al.: The Budd-Chiari syndrome. Medical and surgical management of 30 patients. Arch Surg 1985, 120:657–662.

    PubMed  CAS  Google Scholar 

  40. Sholar PW, Bell WR: Thrombolytic therapy for inferior vena cava thrombosis in paroxysmal nocturnal hemoglobinuria. Ann Intern Med 1985, 103:539–541.

    PubMed  CAS  Google Scholar 

  41. Greenwood LH, Yrizarry JM, Hallett JW, Scoville Jr.GS: Urokinase treatment of Budd-Chiari syndrome. Am J Roentgenol 1983, 141:1057–1059.

    CAS  Google Scholar 

  42. McMullin MF, Hillmen P, Jackson J, et al.: Tissue plasminogen activator for hepatic vein thrombosis in paroxysmal nocturnal haemoglobinuria. J Int Med 1994, 235:85–89.

    Article  CAS  Google Scholar 

  43. Frank JW, Kamath PS, Stanson AW: Budd-Chiari syndrome: early intervention with angioplasty and thrombolytic therapy. Mayo Clin Proc 1994, 69:877–881.

    PubMed  CAS  Google Scholar 

  44. Raju GS, Felver M, Olin JW, Satti SD: Thrombolysis for acute Budd-Chiari syndrome: case report and literature review. Am J Gastroenterol 1996, 91:1262–1263.

    PubMed  CAS  Google Scholar 

  45. Min AD, Atillasoy EO, Schwartz ME, et al.: Reassessing the role of medical therapy in the management of hepatic vein thrombosis. Liver Transpl and Surg 1997, 3:423–429. This study supports the role of early diagnosis of an underlying hematologic disorder followed by appropriate medical therapy. Patients who decompensate with medical treatment can safely undergo transplantation.

    Article  CAS  Google Scholar 

  46. Hagglund H, Ringden O, Ericzon BG, et al.: Treatment of hepatic veno-occlusive disease with recombinant human tissue plasminogen activator or orthotopic liver transplantation after allogeneic bone marrow transplantation. Transplantation 1996, 62:1076–1080.

    Article  PubMed  CAS  Google Scholar 

  47. Yu LC, Malkani I, Regueira O, et al.: Recombinant tissue plasminogen activator (rt-PA) for veno-occlusive liver disease in pediatric autologous bone marrow transplant patients. Am J Hematol 1994, 46:194–198.

    Article  PubMed  CAS  Google Scholar 

  48. Goldstein R, Clark P, Klintmalm G, et al.: Prevention of recurrent thrombosis following liver transplantation for Budd-Chiari syndrome associated with myeloproliferative disorders: treatment with hydroxyurea and aspirin. Transplant Proc 1991, 23:1559–1560.

    PubMed  CAS  Google Scholar 

  49. Klein AS, Cameron JL: Diagnosis and management of the Budd-Chiari syndrome. Am J Surg 1990, 160:128–133.

    Article  PubMed  CAS  Google Scholar 

  50. Klein AS, Sitzman JV, Coleman J, et al.: Current management of the Budd-Chiari syndrome. Ann Surg 1990, 212:144–149.

    Article  PubMed  CAS  Google Scholar 

  51. Hemming AW, Langer B, Greig P, et al.: Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation. Am J Surg 1996, 171:176–181. This study recommends portosystemic shunts for patients with preserved liver function and transplantation for patients with decompensated liver disease.

    Article  PubMed  CAS  Google Scholar 

  52. Orloff MJ, Orloff MS, Daily PO: Long-term results of treatment of Budd-Chiari syndrome with portal decompression. Arch Surg 1992, 127:1182–1187.

    PubMed  CAS  Google Scholar 

  53. Eid A, Rahamimov R, Ilan Y, et al.: Cavoatrial shunt: a graft salvage procedure for suprahepatic caval anastomosis obstruction after liver transplantation. Liver Transpl and Surg 1998, 4:239–240.

    Article  CAS  Google Scholar 

  54. Kuniyoshi Y, Koja K, Akasaki M, et al.: Improvement in esophageal varices and liver histology postoperatively in Budd-Chiari syndrome. Ann Thorac Surg 1998, 65:1711–1714.

    Article  PubMed  CAS  Google Scholar 

  55. Ringe B, Lang H, Oldhafer K, et al.: Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A singlecenter experience with 50 patients. Hepatology 1995, 21:1337–1344.

    PubMed  CAS  Google Scholar 

  56. Chang CH, Lee M-C, Shieh M-J, et al.: Transatrial membranotomy for Budd-Chiari syndrome. Ann Thorac Surg 1989, 48:409–412.

    Article  PubMed  CAS  Google Scholar 

  57. Senning A: Transcaval posterocranial resection of the liver as treatment of the Budd-Chiari syndrome. World J Surg 1983, 7:632–640.

    Article  PubMed  CAS  Google Scholar 

  58. Pasic M, Senning A, von SegesserL, et al.: Transcaval liver resection with hepatoatrial anastomosis for treatment of patients with the Budd-Chiari syndrome. J Thorac Cardiovasc Surg 1993, 106:275–282.

    PubMed  CAS  Google Scholar 

  59. McDonald M, Perkins JD, Ralph D, Carithers Jr.RL: Postoperative care: immediate. In Transplantation of the Liver. Edited by MaddreyWC, SorrellMF. Norwalk: Appleton and Lange; 1995:171–206.

    Google Scholar 

  60. O’Grady JG, Williams R: Postoperative care: long-term. In Transplantation of the Liver. Edited by MaddreyWC, Sorrell, MF. Norwalk: Appleton and Lange; 1995:207–224.

    Google Scholar 

  61. Campbell DA, Rolles K, Jamieson N, et al.: Hepatic transplantation with perioperative and long term anticoagulation as treatment for Budd-Chiari syndrome. Surg Gynecol Obstet 1988, 166:511–518.

    PubMed  Google Scholar 

  62. Shaked A, Goldstein RM, Klintmalm GB, et al.: Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome. Surg Gynecol Obstet 1992, 174:453–459.

    PubMed  CAS  Google Scholar 

  63. Sparano J, Chang J, Trasi S, Bonanno C: Treatment of the Budd-Chiari syndrome with percutaneous transluminal angioplasty. Case report and review of the literature. Am J Med 1987, 82:821–828.

    Article  PubMed  CAS  Google Scholar 

  64. Xu K, He FX, Zhang HG, et al.: Budd-Chiari syndrome caused by obstruction of the hepatic inferior vena cava: immediate and 2-year treatment results of transluminal angioplasty and metallic stent placement. Cardiovasc Intervent Radiol 1996, 19:32–36.

    PubMed  CAS  Google Scholar 

  65. Furui S, Sawada S, Irie T, et al.: Hepatic inferior vena cava obstruction: treatment of two types with Gianturco expandable metallic stents. Radiology 1990, 176:665–670.

    PubMed  CAS  Google Scholar 

  66. Lopez RR, Benner KG, Hall L, et al.: Expandable venous stents for treatment of the Budd-Chiari syndrome. Gastroenterology 1991, 100:1435–1441.

    PubMed  Google Scholar 

  67. Kaul U, Agarwal R, Jain P, et al.: Management of idiopathic obstruction of the hepatic and suprahepatic inferior vena cava with a self-expanding metallic stent. Cathet Cardiovasc Diagn 1996, 39:252–257.

    Article  PubMed  CAS  Google Scholar 

  68. Bilbao JI, Pueyo JC, Longo JM, et al.: Interventional therapeutic techniques in Budd-Chiari syndrome. Cardiovasc Intervent Radiol 1997, 20:112–119. A thorough review of interventional radiologic techniques for managing patients with hepatic venous or caval occlusion. Angioplasty with or without stenting and TIPS are discussed.

    Article  PubMed  CAS  Google Scholar 

  69. Pisanni-Ceretti A, Intra M, Prestipino F, et al.: Surgical and radiologic treatment of primary Budd-Chiari syndrome. World J Surg 1998, 22:48–54. A good review of radiologic and surgical treatment options for patients with Budd Chiari syndrome.

    Article  Google Scholar 

  70. Witte AMC, Kool LJS, Veenendaal R, et al.: Hepatic vein stenting for Budd-Chiari syndrome. Am J Gastroenterol 1997, 92:498–501.

    PubMed  CAS  Google Scholar 

  71. Ochs A, Sellinger M, Haag K, et al.: Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol 1993, 18:217–225.

    Article  PubMed  CAS  Google Scholar 

  72. Blum U, Rossle M, Haag K, et al.: Budd-Chiari Syndrome: technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt. Radiology 1995, 197:805–811.

    PubMed  CAS  Google Scholar 

  73. Ganger DR, Klapman JB, McDonald V, et al.: Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome and portal vein thrombosis. Am J Gastroenterol 1999, 94:603–608. A thorough review of the use of TIPS in the management of patients with hepatic venous outflow obstruction. A nice algorithm is provided for managing patients with either acute or chronic outflow obstruction.

    PubMed  CAS  Google Scholar 

  74. Uhl MD, Roth DB, Reily CA: Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome. Dig Dis Sci 1996, 41:1494–1499.

    Article  PubMed  CAS  Google Scholar 

  75. Shresta R, Durham JD, Wachs M, et al.: Use of transjugular intrahepatic portosystemic shunt as a bridge to transplantation in fulminant hepatic failure due to Budd-Chiari syndrome. Am J Gastroenterol 1997, 92:2304–2306.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Liver Study Unit, Section of Gastroenterology, Dept. of Internal Medicine, The University of Chicago Hospitals and Clinics, 5841 S. Maryland Ave., MC 4076, 60637, Chicago, IL, USA

    Thomas W. Faust MD

Authors
  1. Thomas W. Faust MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Faust, T.W. Budd-Chiari syndrome. Curr Treat Options Gastro 2, 491–504 (1999). https://doi.org/10.1007/s11938-999-0053-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-999-0053-y

Keywords

Search

Navigation